Peuker CA, Yaghobramzi S, Grunert C, Keilholz L, et al. Treatment with ribociclib shows favourable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial. Eur J Cancer 2021;162:45-55.
PMID: 34953442